Nanobiosystem Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 20

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Investors
  • 8

Nanobiosystem General Information

Description

Developer of advanced regenerative medical devices and biotechnology products designed for human tissue restoration. The company's technology utilizes extracellular matrix simulation, nanoregenerative scaffold technology, and high-precision particle technology, providing the healthcare and aesthetic sectors with absorbable tissue regeneration guides, eardrum regeneration patches, and bone regeneration guides to restore damaged human tissues to their original state using biomimetic scaffolds.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 43-22, Room 1820, Building A
  • Cheomdangwagi-ro, 208Beon-gil, Buk-gu
  • Gwangju, Jeollanam
  • South Korea
+82
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 43-22, Room 1820, Building A
  • Cheomdangwagi-ro, 208Beon-gil, Buk-gu
  • Gwangju, Jeollanam
  • South Korea
+82

Nanobiosystem Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Nanobiosystem Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Accelerator/Incubator 09-Sep-2024 Completed Generating Revenue
4. Accelerator/Incubator 07-Nov-2023 Completed Startup
3. Later Stage VC (Series A) 17-Aug-2023 Completed Startup
2. Later Stage VC 28-Dec-2022 $2.3M $2.3M Completed Startup
1. Seed Round 07-Nov-2017 Completed Startup
To view Nanobiosystem’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Nanobiosystem Patents

Nanobiosystem Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026116816-A1 System and method for manufacturing skin regeneration patch assembly Pending 27-Nov-2024
WO-2026071526-A1 Skin regeneration patch assembly and manufacturing method therefor Pending 24-Sep-2024
WO-2025174205-A1 Eardrum regeneration patch Pending 14-Feb-2024
WO-2025174205-A9 Eardrum regeneration patch Pending 14-Feb-2024
US-20250169957-A1 Cartilage regeneration scaffold and preparing method for the same Pending 28-Nov-2023 A61L27/18
To view Nanobiosystem’s complete patent history, request access »

Nanobiosystem Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Nanobiosystem Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
IBK Changgong Accelerator/Incubator
Tech Incubator Program for Startup Accelerator/Incubator
365mc Corporation Minority
Meritz Securities Investment Bank Minority
Mira Ventures Venture Capital Minority
You’re viewing 5 of 8 investors. Get the full list »

Nanobiosystem FAQs

  • When was Nanobiosystem founded?

    Nanobiosystem was founded in 2017.

  • Where is Nanobiosystem headquartered?

    Nanobiosystem is headquartered in Gwangju, South Korea.

  • What is the size of Nanobiosystem?

    Nanobiosystem has 20 total employees.

  • What industry is Nanobiosystem in?

    Nanobiosystem’s primary industry is Drug Discovery.

  • Is Nanobiosystem a private or public company?

    Nanobiosystem is a Private company.

  • What is Nanobiosystem’s current revenue?

    The current revenue for Nanobiosystem is .

  • How much funding has Nanobiosystem raised over time?

    Nanobiosystem has raised $37.4M.

  • Who are Nanobiosystem’s investors?

    IBK Changgong, Tech Incubator Program for Startup, 365mc, Meritz Securities, and Mira Ventures are 5 of 8 investors who have invested in Nanobiosystem.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process